The current standard treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma primarily consists of intensified salvage therapy and, if the disease is chemo-sensitive, high dose therapy followed with autologous stem cell transplantation.
http://www.biomedcentral.com/1471-2407/13/308/abstract
http://www.biomedcentral.com/1471-2407/13/308/abstract
No comments:
Post a Comment